Screening for hereditary cancer and genetic testing, epitomized by breast cancer. (Q33859275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10711238%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Screening for hereditary cancer and genetic testing, epitomized by breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10711238%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

Eeles RA

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10711238%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10711238%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10711238%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10711238%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10711238%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1954-1962

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10711238%20AND%20SRC:MED&resulttype=core&format=json

Age at onset as an indicator of familial risk of breast cancer

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Linkage of early-onset familial breast cancer to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Familial breast-ovarian cancer locus on chromosome 17q12-q23

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

BRCA1Mutations in a Population-Based Sample of Young Women with Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Germline BRCA1 185delAG mutations in Jewish women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

A Large Kindred With 17q-Linked Breast and Ovarian Cancer: Genetic, Phenotypic, and Genealogical Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Cancer risks in BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Uptake of presymptomatic predictive testing for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Genetic testing in breast/ovarian cancer (BRCA1) families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Screening by mammography, women with a family history of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Risk modifiers in carriers of brca1 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Effect of Smoking on Breast Cancer in Carriers of Mutant BRCA1 or BRCA2 Genes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

BRCA1, BRCA2 and their possible function in DNA damage response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Transcriptional activation functions in BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Transcriptional activation by BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Attitudes about genetic testing for breast-ovarian cancer susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Presymptomatic diagnosis of familial adenomatous polyposis by bridging DNA markers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN2 syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900246-4

7 January 2021

10.1016/S0959-8049(99)00246-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10711238%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference